Plasma prolidase levels as a biomarker for polycystic ovary syndrome.

Abstract excerpt

AIM: Assessment of plasma prolidase levels in polycystic ovary syndrome (PCOS). PATIENTS & METHODS: PCOS patients were screened according to Rotterdam Criterion and prolidase levels were measured. RESULTS: A total of 170 patients and 160 controls were recruited for the study and it was found that prolidase levels were significantly higher in PCOS group (991.10 ± 39.52) than control (621.89 ± 23.94). Furthermore...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Case-Control Studies
• Share to Dipeptidases